226 top medical experts on Antithrombin III Deficiency across 31 countries and 21 U.S. states, including 66 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Antithrombin III Deficiency: An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Thrombophilia (2,217), Inherited Blood Coagulation Disorders (1,267), Blood Protein Disorders (103).
  4. Clinical Trials ClinicalTrials.gov : at least 14 including 1 Active, 7 Completed


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. James, Andra H   Maternal & Fetal Medicine   Google Publications
    Department of Obstetrics and Gynecology, Duke University, Durham, NC, United States. Electronic address: . Top Hospital
    Physician  Clinical Trial 
    Disclosed payments in 2021 from 13 biomedical companies, totalling $9,352.02, including $7,552.02 from  Octapharma USA, Inc.
    Subjects: Anticoagulants; Antithrombin III; Heparin, Low-Molecular-Weight; Venous Thrombosis
    Categories: Administration & Dosage; Drug Therapy; Prevention & Control
    Management of hereditary antithrombin deficiency in pregnancy. (2017)
    Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data. (2016)

  2. Paidas, Michael J   Maternal & Fetal Medicine  Google Publications
    Yale Women and Childrens Center for Blood Disorders and Preeclampsia Advancement, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, United States. Top Hospital
    Physician  Highly Published  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 66/100
    Disclosed payments in 2021 from 2 biomedical companies, totalling $2,500, including $2,500 from  Janssen Research & Development, LLC
    Subjects: Anticoagulants; Venous Thromboembolism; Antithrombin III; Antithrombins; Heparin, Low-Molecular-Weight
    Categories: Administration & Dosage; Drug Therapy; Blood; Complications; Prevention & Control; Therapeutic Use
    Clinical syndromes associated with acquired antithrombin deficiency via microvascular leakage and the related risk of thrombosis. (2014)
    Management of hereditary antithrombin deficiency in pregnancy. (2017)

  3. Shavit, Jordan A   Pediatric Hematology-Oncology  Google Publications
    Department of Pediatrics and Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI.
    Physician 
    Relevant US NIH Grant Funding: $1,162,500 over the last 5 years
    Medical school: Northwestern University Feinberg Medical School (MD, 2000)
    Medicare Accepted
    Disclosed payments in 2021 from 14 biomedical companies, totalling $8,748.94, including $2,519.9 from  HEMA Biologics, LLC
    Subjects: Antithrombin III; Disease Models, Animal; Disseminated Intravascular Coagulation; Zebrafish Proteins
    Categories: Genetics
    Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function. (2014)

  4. Kumar, Riten   Pediatric Hematology-Oncology   Google Publications
    Department of Pediatrics, Division of Hematology/Oncology, Nationwide Childrens Hospital, The Ohio State University, Columbus, OH, USA. Top Hospital
    Physician  Case Reports 
    Subjects: Antithrombin III; Genetic Association Studies; Mutation
    Categories: Genetics; Diagnosis
    Molecular structural analysis of a novel and de-novo mutation in the SERPINC1 gene associated with type 1 antithrombin deficiency. (2017)
    c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency. (2015)

  5. Corral, Javier   Google Publications
    Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB, Centro de Investigación Biomédica en Red de Enfermedades Raras CIBERER, Murcia, Spain.
    Scientist  Highly Cited  Highly Published  Case Reports 
    Subjects: Antithrombin III; Mutation; Thrombosis; Genetic Predisposition to Disease; Thrombophilia
    Categories: Genetics; Diagnosis; Chemistry; Metabolism; Complications; Physiopathology
    The genetics of antithrombin. (2018)
    Management of antithrombin deficiency: an update for clinicians. (2019)

  6. Vicente, Vicente  Google Publications
    Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB, Centro de Investigación Biomédica en Red de Enfermedades Raras CIBERER, Murcia, Spain.
    Scientist  Highly Cited  Highly Published  Case Reports 
    Subjects: Antithrombin III; Mutation; Thrombosis; Genetic Predisposition to Disease; Venous Thrombosis
    Categories: Genetics; Chemistry; Metabolism; Diagnosis; Blood; Analysis
    The genetics of antithrombin. (2018)
    Management of antithrombin deficiency: an update for clinicians. (2019)

  7. Liu, Yang   Pediatric Anesthesiology  Google Publications
    Department of Pediatrics and.
    Physician 
    Subjects: Antithrombin III; Disease Models, Animal; Disseminated Intravascular Coagulation; Zebrafish Proteins
    Categories: Genetics
    Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function. (2014)

  8. Konkle, Barbara A   Hematology  Google Publications
    Bloodworks Northwest, Department of Medicine, University of Washington, Seattle, WA, United States. Top Hospital
    Physician 
    Medical school: Vanderbilt University School of Medicine (MD, 1979)
    Medicare Accepted
    Disclosed payments in 2021 from 11 biomedical companies, totalling $35,492.9, including $16,645 from  PFIZER INC.
    Categories: Drug Therapy
    Management of hereditary antithrombin deficiency in pregnancy. (2017)

  9. Levy, Jerrold H   Anesthesiology   Google Publications
    Jerrold H. Levy, MD, FAHA, FCCM, DUMC 3094, Durham, NC 27710, USA, Tel.: +1 919 681 6614, Fax: +1 919 681 8994, E-mail: .
    Physician 
    Disclosed payments in 2021 from 11 biomedical companies, totalling $15,076.86, including $4,375 from  Merck Sharp & Dohme Corporation
    Subjects: Anti-Inflammatory Agents; Anticoagulants; Antithrombins; Disseminated Intravascular Coagulation; Sepsis
    Categories: Drug Therapy; Therapeutic Use
    Antithrombin: anti-inflammatory properties and clinical applications. (2016)

  10. Martínez-Martínez, Irene  Google Publications
    Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
    Scientist  Highly Published  Case Reports 
    Subjects: Antithrombin III; Mutation; Antithrombin Proteins; Mutant Proteins; Thrombosis
    Categories: Genetics; Metabolism; Chemistry; Complications; Etiology
    Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. (2012)
    Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency. (2016)

  11. Oldenburg, Johannes    Google Publications
    Physician  Highly Published  Case Reports 
    Subjects: Antithrombin III; Mutation; Factor IX; Hematoma; Protein C
    Categories: Genetics; Antagonists & Inhibitors; Drug Therapy; Etiology
    Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort. (2012)
    Molecular basis of antithrombin deficiency. (2011)

  12. de, la Morena-Barrio María Eugenia  Google Publications
    Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, IMIB, CIBERER, Universidad de Murcia, Murcia, Spain.
    Scientist  Highly Published  Case Reports 
    Subjects: Antithrombin III; Thrombosis; Genetic Predisposition to Disease; Mutation; Venous Thrombosis
    Categories: Genetics; Diagnosis; Metabolism; Complications; Congenital; Epidemiology
    The genetics of antithrombin. (2018)
    Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. (2012)

  13. Benkwitz, Claudia   Pediatric Anesthesiology  Google Publications
    Department of Anesthesia and Perioperative Care, UCSF Benioff Childrens Hospital, San Francisco, CA.
    Physician  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 100/100
    Subjects: Antithrombin III; Blood Coagulation; Cardiac Surgical Procedures; Heart Defects, Congenital; Postoperative Hemorrhage
    Categories: Methods; Drug Effects; Drug Therapy; Pharmacology; Prevention & Control; Surgery
    Double-Blind, Randomized, Placebo-Controlled Trial Comparing the Effects of Antithrombin Versus Placebo on the Coagulation System in Infants with Low Antithrombin Undergoing Congenital Cardiac Surgery. (2019)

  14. Jagadeeswaran, Pudur  Google Publications
    UNIVERSITY OF NORTH TEXAS.
    Scientist 
    Subjects: Antithrombin III; Disease Models, Animal; Disseminated Intravascular Coagulation; Zebrafish Proteins
    Categories: Genetics
    Zinc fingers poke zebrafish, cause thrombosis! (2014)

  15. Navarro-Fernández, José  Google Publications
    Dr. Javier Corral, University of Murcia, Centro Regional de Hemodonación, Calle Ronda de Garay s/n. Murcia 30003, Spain, Tel.: +34 968341990, Fax: +34 968261914, E-mail:.
    Scientist  Highly Published  Case Reports 
    Subjects: Antithrombin III; Mutation; Antithrombin Proteins; Mutant Proteins; Thrombosis
    Categories: Genetics; Metabolism; Chemistry; Blood; Analysis; Complications
    Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. (2012)
    Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency. (2016)

  16. Pabinger, Ingrid  Google Publications
    Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
    Scientist  Case Reports 
    Subjects: Anticoagulants; Antithrombins; Contraceptives, Oral, Hormonal; Thrombosis; Venous Thromboembolism
    Categories: Drug Therapy; Therapeutic Use; Adverse Effects; Complications
    How I treat patients with hereditary antithrombin deficiency. (2019)

  17. Shah, Nirmish   Internal Medicine  Google Publications
    Division of Pediatric Hematology/Oncology, Duke University Medical Center, Durham, NC. Top Hospital
    Physician  Clinical Trial 
    Medical school: Other (MD, 2000)
    Medicare Accepted
    Disclosed payments in 2021 from 79 biomedical companies, totalling $122,434.65, including $87,992.91 from  Global Blood Therapeutics, Inc.
    Subjects: Antithrombin III; Blood Coagulation; Cardiac Surgical Procedures; Heart Defects, Congenital; Postoperative Hemorrhage
    Categories: Methods; Drug Effects; Drug Therapy; Pharmacology; Prevention & Control; Surgery
    Double-Blind, Randomized, Placebo-Controlled Trial Comparing the Effects of Antithrombin Versus Placebo on the Coagulation System in Infants with Low Antithrombin Undergoing Congenital Cardiac Surgery. (2019)

  18. Thaler, Johannes  Google Publications
    Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
    Scientist  Case Reports 
    Subjects: Anticoagulants; Antithrombins; Contraceptives, Oral, Hormonal; Thrombosis; Venous Thromboembolism
    Categories: Drug Therapy; Therapeutic Use; Adverse Effects; Complications
    How I treat patients with hereditary antithrombin deficiency. (2019)

  19. Ageno, Walter    Google Publications
    Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.
    Physician  Highly Published 
    Subjects: Venous Thromboembolism; Antithrombin III; Protein C Deficiency; Protein S Deficiency; Severity of Illness Index
    Categories: Complications; Epidemiology; Blood; Analysis; Etiology
    Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies. (2015)
    Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study. (2014)

  20. Dentali, Francesco    Google Publications
    Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.
    Physician  Highly Published 
    Subjects: Venous Thromboembolism; Antithrombin III; Protein C Deficiency; Protein S Deficiency; Severity of Illness Index
    Categories: Complications; Epidemiology; Blood; Analysis; Etiology
    Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies. (2015)
    Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study. (2014)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);